Human Investing’s Thermo Fisher Scientific TMO Stock Holding History

Human Investing’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$336K	Buy	671 +9	+1%	+$4.32K	0.04%	77
2026 Q1	$325K	Buy	662 +2	+0.3%	+$1.08K	0.05%	75
2025 Q4	$383K	Buy	+660	New	+$373K	0.05%	70
2025 Q3	–	Sell	-652	Closed	-$264K	–	97
2025 Q2	$264K	Sell	652 -7	-1%	-$2.93K	0.04%	81
2025 Q1	$328K	Hold	659	–	–	0.06%	70
2024 Q4	$343K	Sell	659 -1	-0.2%	-$550	0.06%	71
2024 Q3	$408K	Buy	660 +7	+1%	+$4.14K	0.07%	67
2024 Q2	$361K	Sell	653 -1	-0.2%	-$573	0.07%	67
2024 Q1	$380K	Sell	654 -50	-7%	-$28.1K	0.08%	68
2023 Q4	$374K	Hold	704	–	–	0.08%	70
2023 Q3	$356K	Buy	+704	New	+$375K	0.08%	74
2020 Q4	–	Sell	-77	Closed	-$34K	–	331
2020 Q3	$34K	Buy	+77	New	+$31.8K	0.01%	177
2019 Q1	–	Sell	-19	Closed	-$4K	–	416
2018 Q4	$4K	Buy	+19	New	+$4.46K	﹤0.01%	321

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Human Investing's TMO Position: Q2 2026 in Review

Human Investing increased its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, buying an estimated $4.32K and bringing the position to 671 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #77.

Human Investing first reported a position in TMO in Q4 2018 and has held it in 13 quarters since. The position peaked at $408K in Q3 2024. 1,174 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Human Investing held 671 shares of Thermo Fisher Scientific worth $336K as of Q2 2026.
Human Investing bought 9 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.32K.
Thermo Fisher Scientific made up 0.04% of Human Investing's portfolio in Q2 2026, its #77 holding.
Human Investing first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 13 quarters since.
Human Investing's Thermo Fisher Scientific position peaked at $408K in Q3 2024.
1,174 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.